{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:40:11Z","timestamp":1732678811226,"version":"3.28.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.transci.2024.104004","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T05:25:25Z","timestamp":1726377925000},"page":"104004","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does immunohistochemical staining predict mobilization success in multiple myeloma patients?"],"prefix":"10.1016","volume":"63","author":[{"given":"Fatma Keklik","family":"Karadag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Aysin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajda","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Bozer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysenur","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"T\u00f6b\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Vural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.transci.2024.104004_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2024.104004_bib2","first-page":"S3","article-title":"Current approaches to management of newly diagnosed multiple myeloma","volume":"97","author":"Goel","year":"2022","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.transci.2024.104004_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1537-2995.2011.03385.x","article-title":"Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Societ\u00e0 Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process","volume":"52","author":"Pierelli","year":"2012","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.transci.2024.104004_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/14653249.2012.681042","article-title":"Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization","volume":"14","author":"Sancho","year":"2012","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/vox.12183","article-title":"Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience","volume":"107","author":"Lee","year":"2014","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.transci.2024.104004_bib7","first-page":"1051","article-title":"A retrospective study of autologous stem cell mobilization by G-CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma","volume":"19","author":"Zheng","year":"2020","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.transci.2024.104004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.06.023","article-title":"Predictive factors for stem cell mobilization failure in multiple myeloma patients: a single center experience","volume":"59","author":"Goker","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"9","key":"10.1016\/j.transci.2024.104004_bib9","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.transci.2024.104004_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s002770100351","article-title":"Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma","volume":"80","author":"Perea","year":"2001","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41409-017-0051-y","article-title":"Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score","volume":"53","author":"Olivieri","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.104004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2022.103351","article-title":"Outcomes of stem cell mobilization and engraftment in patients with multiple myeloma according to CD56 expression status","volume":"61","author":"Iltar","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2024.104004_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jca.21864","article-title":"Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?","volume":"36","author":"G\u00f6\u00e7er","year":"2021","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2559.2004.01834.x","article-title":"Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis","volume":"44","author":"Mart\u00edn","year":"2004","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000489483","article-title":"CD56 expression is an important prognostic factor in multiple myeloma even with bortezomib induction","volume":"139","author":"Skerget","year":"2018","journal-title":"Acta Haematol"},{"issue":"6","key":"10.1016\/j.transci.2024.104004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103249","article-title":"Does myeloma genetic have an effect on stem cell mobilization?","volume":"60","author":"Ba\u015fc\u0131","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2024.104004_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-018-0691-4","article-title":"Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial","volume":"12","author":"Saltarella","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.transci.2024.104004_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.transci.2024.104004_bib19","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.transci.2024.104004_bib20","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.transci.2024.104004_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00277-021-04475-2","article-title":"The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma","volume":"100","author":"Jin","year":"2021","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2024.104004_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0971-5851.125246","article-title":"Cyclin D1 expression in multiple myeloma by immunohistochemistry: case series of 14 patients and literature review","volume":"34","author":"Padhi","year":"2013","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"7","key":"10.1016\/j.transci.2024.104004_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ajh.23223","article-title":"Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents","volume":"87","author":"Tasidou","year":"2012","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.transci.2024.104004_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2141.2000.02007.x","article-title":"Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance","volume":"109","author":"Hoechtlen-Vollmar","year":"2000","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.transci.2024.104004_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41409-019-0676-0","article-title":"Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor","volume":"55","author":"Morris","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2024.104004_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102722","article-title":"Inferior prognosis in poor mobilizing myeloma patients","volume":"59","author":"Yi\u011feno\u011flu","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.transci.2024.104004_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2014.322","article-title":"Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation","volume":"50","author":"Brioli","year":"2015","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"10.1016\/j.transci.2024.104004_bib28","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V91.9.3148","article-title":"High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation","volume":"91","author":"Ketterer","year":"1998","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T02:51:44Z","timestamp":1732675904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1473050224001757"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.104004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does immunohistochemical staining predict mobilization success in multiple myeloma patients?","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.104004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104004"}}